A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment
As treatment options for patients with rectal cancer evolve, patients with early-stage rectal cancer may have a treatment choice between surgery and a trial of nonoperative management. Patients must consider the treatments’ clinical tradeoffs alongside their personal goals and preferences. Shared de...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2023-12-01
|
Series: | Annals of Surgery Open |
Online Access: | http://journals.lww.com/10.1097/AS9.0000000000000364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832589696347144192 |
---|---|
author | Merrill E. Rubens Timothy P. Mayo Radhika K. Smith Sean C. Glasgow Mary C. Politi |
author_facet | Merrill E. Rubens Timothy P. Mayo Radhika K. Smith Sean C. Glasgow Mary C. Politi |
author_sort | Merrill E. Rubens |
collection | DOAJ |
description | As treatment options for patients with rectal cancer evolve, patients with early-stage rectal cancer may have a treatment choice between surgery and a trial of nonoperative management. Patients must consider the treatments’ clinical tradeoffs alongside their personal goals and preferences. Shared decision-making (SDM) between patients and clinicians can improve decision quality when patients are faced with preference-sensitive care options. We interviewed 28 stakeholders (13 clinicians and 15 patients) to understand their perspectives on early-stage rectal cancer treatment decision-making. Clinicians included surgeons, medical oncologists, and radiation oncologists who treat rectal cancer. Adult patients included those diagnosed with early-stage rectal cancer in the past 5 years, recruited from an institutional database. A semi-structured interview guide was developed based on a well-established decision support framework and reviewed by the research team and stakeholders. Interviews were conducted between January 2022 and January 2023. Transcripts were coded by 2 raters and analyzed using thematic analysis. Both clinicians and patients recognized the importance of SDM to support high-quality decisions about the treatment of early-stage rectal cancer. Barriers to SDM included variable clinician motivation due to lack of training or perception of patients’ desires or abilities to engage, as well as time-constrained encounters. A decision aid could help facilitate SDM for early-stage rectal cancer by providing standardized, evidence-based information about treatment options that align with clinicians’ and patients’ decision needs. |
format | Article |
id | doaj-art-5441e15f0dbe4cd999c973b430cc8e30 |
institution | Kabale University |
issn | 2691-3593 |
language | English |
publishDate | 2023-12-01 |
publisher | Wolters Kluwer Health |
record_format | Article |
series | Annals of Surgery Open |
spelling | doaj-art-5441e15f0dbe4cd999c973b430cc8e302025-01-24T09:18:12ZengWolters Kluwer HealthAnnals of Surgery Open2691-35932023-12-0144e36410.1097/AS9.0000000000000364202312000-00030A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer TreatmentMerrill E. Rubens0Timothy P. Mayo1Radhika K. Smith2Sean C. Glasgow3Mary C. Politi4From the * Department of SurgeryFrom the * Department of Surgery† Section of Colon and Rectal Surgery, Department of Surgery† Section of Colon and Rectal Surgery, Department of Surgery‡ Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, MO.As treatment options for patients with rectal cancer evolve, patients with early-stage rectal cancer may have a treatment choice between surgery and a trial of nonoperative management. Patients must consider the treatments’ clinical tradeoffs alongside their personal goals and preferences. Shared decision-making (SDM) between patients and clinicians can improve decision quality when patients are faced with preference-sensitive care options. We interviewed 28 stakeholders (13 clinicians and 15 patients) to understand their perspectives on early-stage rectal cancer treatment decision-making. Clinicians included surgeons, medical oncologists, and radiation oncologists who treat rectal cancer. Adult patients included those diagnosed with early-stage rectal cancer in the past 5 years, recruited from an institutional database. A semi-structured interview guide was developed based on a well-established decision support framework and reviewed by the research team and stakeholders. Interviews were conducted between January 2022 and January 2023. Transcripts were coded by 2 raters and analyzed using thematic analysis. Both clinicians and patients recognized the importance of SDM to support high-quality decisions about the treatment of early-stage rectal cancer. Barriers to SDM included variable clinician motivation due to lack of training or perception of patients’ desires or abilities to engage, as well as time-constrained encounters. A decision aid could help facilitate SDM for early-stage rectal cancer by providing standardized, evidence-based information about treatment options that align with clinicians’ and patients’ decision needs.http://journals.lww.com/10.1097/AS9.0000000000000364 |
spellingShingle | Merrill E. Rubens Timothy P. Mayo Radhika K. Smith Sean C. Glasgow Mary C. Politi A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment Annals of Surgery Open |
title | A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment |
title_full | A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment |
title_fullStr | A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment |
title_full_unstemmed | A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment |
title_short | A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment |
title_sort | qualitative exploration of stakeholders preferences for early stage rectal cancer treatment |
url | http://journals.lww.com/10.1097/AS9.0000000000000364 |
work_keys_str_mv | AT merrillerubens aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT timothypmayo aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT radhikaksmith aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT seancglasgow aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT marycpoliti aqualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT merrillerubens qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT timothypmayo qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT radhikaksmith qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT seancglasgow qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment AT marycpoliti qualitativeexplorationofstakeholderspreferencesforearlystagerectalcancertreatment |